With a Bayer-Sanofi Executive Switch, Sanofi Creates Two New Global Business Units

Paris-based Sanofi announced it is refocusing two of its international business units. The goal is to create more focus on mature markets and emerging markets.

The company plans to form a new Primary Care global business unit. It will combine the product portfolios from its existing Diabetes and Cardiovascular (DCV) unit with Established Products, which are presently part of the General Medicines & Emerging Markets (GEM) global business unit. This new Primary Care unit will focus its operations and resources on mature markets.